Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash turns positive

Q1 FY2026 net change in cash was $8.75K, compared with -$428 a year earlier. Trailing-twelve-month net change in cash was $12.79K.

What to watch

Whether quarterly net change in cash holds near $8.75K or moves back toward the trailing-twelve-month quarterly average of $3.2K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.75K+61.4% QoQ
Last fiscal yearDec 2025
$4.79K+254.3% YoY
LTMMar 2026
$12.79K+174.6% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2144.4%——
1 year+254.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
4.79K USD
Year-over-year change
+254.3%
1-year CAGR
+254.3%

Net Change in Cash vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 net change in cash of $12.79K is the smallest of the 10 companies compared; the peer median is $479.17K.
  • Its year-over-year change of +174.6% is the 2nd highest of 4, against a peer median of -108.5%.
DMAA Competitors Peer median
Net Change in Cash for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesFY2025$1.33M ———
MLACMountain Lake Acquisition Corp.FY2025$930.71K -167.3%+128.1%—
OYSEOyster Enterprises II Acquisition CorpFY2025$864.58K ———
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$558.09K ———
TACOUBerto Acquisition Corp. UnitFY2025$544.64K ———
TACOBerto Acquisition Corp.FY2025$544.64K ———
TACHTitan Acquisition Corp.LTM Mar 2026$479.17K +2821592.1%——
ALFCenturion Acquisition Corp.LTM Mar 2026$463.43K ———
SIMASIM Acquisition Corp. ILTM Mar 2026$43.3K -108.5%——
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$12.79K +174.6%——
Peer median (excluding DMAA) $479.17K-108.5%+128.1%—

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.